Soft-tissue sarcomas are tumors that can happen in many different tissues in the body. Most soft-tissue sarcomas begin in the arms, legs, or the body wall. People usually first notice a painless lump, ...

For most types of STS and for earlier stages of sarcoma, the treatment is usually similar. People may have surgery alone, or radiation therapy or chemotherapy in addition to surgery. Treatment may ...

Patients with non-metastatic soft tissue sarcoma (STS) who need pre-operative radiation therapy can safely receive hypofractionated treatment over three weeks instead of five, with comparable tumor ...

Soft tissue sarcoma is a type of cancerous tumor that forms in the body’s soft tissues, such as muscle, fat, fibrous tissue, and blood vessels. If it occurs in the shoulder, it might feel like a ...

Soft tissue sarcoma recovery extends beyond physical healing, emphasizing social engagement and emotional well-being for improved quality of life. Pain and daily activity participation are major ...

A phase II study of gimatecan as salvage treatment in patients with advanced or metastatic soft tissue sarcoma (STS) relapsing after anthracycline / ifosfamide - based chemotherapy regimens No ...

Combining immunotherapy with radiation could be a promising treatment option for patients with advanced soft tissue sarcoma, according to the results of a clinical trial led by Northwestern Medicine ...

CHICAGO ― In a Phase II clinical trial, immune checkpoint blockade before surgery was associated with favorable responses and outcomes in undifferentiated pleomorphic sarcoma (UPS) and recurrent ...

The O’Neal Comprehensive Cancer Center’s Skin & Soft Tissue Cancer Management Team in partnership with the UAB Division of Surgical Oncology has received a SARC Core Center designation from the ...

Counseling and DNA Testing for Individuals Perceived to Be Genetically Predisposed to Melanoma: A Consensus Statement of the Melanoma Genetics Consortium PURPOSE: To define the rate of local ...

In patients with mostly undifferentiated pleomorphic sarcomas, 2-year DFS with the addition of preoperative and postoperative pembrolizumab (Keytruda) infusions reached 67%, as compared with 52% with ...

A team of researchers at Mayo Clinic has discovered that using fluorescent green dye combined with imaging during surgery for soft tissue sarcoma can help surgeons determine what tissue may be at risk ...